Press Releases

Date	Title	Company
13-Jun-2022	Global Silicone Polymer Market Report to 2028 - by Type, End-use Industry and Region - ResearchAndMarkets.com	Businesswire
13-Jun-2022	PharmaCyte Biotech to Attend 2022 BIO International Convention in San Diego	Businesswire
13-Jun-2022	Organon Enters into Global License Agreement to Commercialize Henlius’ Investigational Perjeta® (Pertuzumab) and Prolia®/Xgeva® (Denosumab) Biosimilar Candidates	Businesswire
13-Jun-2022	Asher Bio Appoints Andrea Pirzkall, M.D., as Chief Medical Officer	Businesswire
13-Jun-2022	Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the Group	Businesswire
13-Jun-2022	Elektrofi Raises $40 Million Financing to Establish GMP Manufacturing Capabilities for Upcoming Clinical Studies and Expand Development Pipeline	Businesswire
13-Jun-2022	ATCC Awarded Two Contracts from Gennova Biopharmaceuticals for the Continued Development of Cell Banks to Help Diagnose and Prevent Leishmaniasis	Businesswire
13-Jun-2022	Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A	Businesswire
13-Jun-2022	Cortexyme Appoints June Bray to its Board of Directors	Businesswire
13-Jun-2022	Evecxia Therapeutics Announces Leadership Transition to Support Next Phase of Development and Growth	Businesswire
13-Jun-2022	Global Neuroimmunology Drug Development Report 2022: Top 20 Neuroimmunology Products Forecast to be Worth $26.6 Billion by 2025 - ResearchAndMarkets.com	Businesswire
13-Jun-2022	BeiGene Announces BRUKINSA™ (zanubrutinib) Is Approved in 50 Markets	Businesswire
13-Jun-2022	ADC Therapeutics Names David Gilman as Chief Business & Strategy Officer	Businesswire
13-Jun-2022	Injectable Benzodiazepine Market to grow at 2.7% CAGR through 2030	MARKITWIRED
13-Jun-2022	Canine Atopic Dermatitis Treatment Market will surpass US$ 2.4 Billion in 2029	MARKITWIRED
13-Jun-2022	Cotinine Screening Devices Market is expected to increase at a CAGR of ~4.7% over the forecast period of 2022-2029	MARKITWIRED
13-Jun-2022	BeiGene Announces PDUFA Goal Date Extension for U.S. sNDA for BRUKINSA for the Treatment of CLL/SLL	Businesswire
13-Jun-2022	Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS	Businesswire
13-Jun-2022	FDA Accepts Application for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Stage IB (≥4 centimeters)-IIIA Non-Small Cell Lung Cancer Following Complete Surgical Resection	Businesswire
13-Jun-2022	Volta Inc. Board of Directors Announces Executive Leadership Team Additions and Key Promotions	Businesswire